FDA Approves Unknown Drug — SUN PHARM INDS INC
SUN PHARM INDS INC announced today the receipt of FDA approval for the competition-friendly ANDA040446. This regulatory win is likely to bolster the company's generic portfolio and provide a new catalyst for its growth trajectory.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day